News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Alexion Pharmaceuticals Inc. to Present at Investor Conferences
August 29, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at two upcoming investor conferences:
Twitter
LinkedIn
Facebook
Email
Print
Events
Alexion
MORE ON THIS TOPIC
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
May 20, 2026
·
4 min read
·
Heather McKenzie
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
May 5, 2026
·
4 min read
·
Heather McKenzie
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
April 28, 2026
·
5 min read
·
Andrea Park
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
